3P1I

ligand binding domain of human ephrin type-b receptor 3

• Total interactions analyzed: 3
• Total true interactions: 3
• Strongest Interaction:
  • Chains: A-B
  • Int. Res.: 35
  • Norm. En. per Res.: -2.254
• Hub Node: A(2)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	-14.8875	3.0311	-67.0338	-78.8902	35	2	0	2406	0	4	4
A-C	-11.3849	0.0	-120.672	-132.0569	81	18	1	5794	1	12	10
B-C	-2.8528	22.4662	-95.7302	-76.1169	45	1	0	3805	1	11	15

Interface residues

• A-B: ALA192B, ARG84A, ASN121A, ASN152B, ASN89B, GLN194B, GLN196B, GLN88B, GLU151B, GLU85A, GLY124A, HIS57B, ILE119A, ILE122A, LYS156B, MET150B, PHE133B, PHE148B, PRO120A, PRO123A, PRO153B, PRO58B, SER118A, SER125A, SER86A, SER86B, SER87A, SER87B, TRP149B, TRP91B, TYR134B, TYR135B, TYR154B, VAL155B, VAL83A
• A-C: ALA171A, ALA198A, ALA71A, ALA71C, ARG114A, ARG114C, ARG173C, ARG76A, ARG76C, ARG84A, ARG84C, ASN121A, ASN121C, ASN73A, ASN73C, ASN82A, ASN82C, ASP115A, ASP115C, ASP69A, ASP69C, CYS116A, CYS116C, CYS199A, CYS199C, CYS81A, CYS81C, GLN79A, GLN79C, GLU63A, GLU63C, GLU64A, GLU64C, GLU70A, GLU70C, GLU85A, GLU85C, GLY172A, GLY172C, GLY61A, GLY61C, GLY67A, GLY67C, ILE119A, ILE119C, ILE122A, ILE122C, ILE75A, ILE75C, MET200A, MET200C, MET72A, MET72C, PHE166A, PHE166C, PRO120A, PRO120C, PRO74A, PRO74C, SER118A, SER118C, SER165A, SER167A, SER201A, SER201C, SER60C, SER66A, SER66C, THR77A, THR77C, TRP62A, TYR68A, TYR68C, VAL174A, VAL174C, VAL65A, VAL65C, VAL80A, VAL80C, VAL83A, VAL83C
• B-C: ALA142B, ALA144B, ALA71C, ARG206C, ASN152B, ASN73C, ASP138B, ASP140B, ASP44C, ASP69C, GLU108C, GLU151B, GLU39C, GLU40C, GLU70C, HIS57B, ILE75C, LYS110C, LYS210C, LYS46C, MET150B, MET72C, PHE148B, PHE208C, PHE96B, PRO147B, PRO153B, PRO74C, SER139B, SER143B, SER145B, SER146B, THR176C, THR41C, THR45C, THR49C, TRP149B, TRP47C, TRP98B, TYR135B, TYR154B, TYR209C, VAL141B, VAL174C, VAL48C